Takeda faces ‘pay-for-delay’ class-action suit over anti-constipation drug

05-08-2021

Alex Baldwin

Takeda faces ‘pay-for-delay’ class-action suit over anti-constipation drug

Jonathan Weiss / Shutterstock.com

Takeda Pharmaceuticals is the target of a proposed class action that alleges the pharma giant paid to keep a generic anti-constipation drug off the market.


Takeda, Par Pharmaceuticals, US District Court for the District of Massachusetts, KPH Healthcare Services, Kinney Drugs

LSIPR